CymitQuimica logo

CAS 171656-50-1

:

Igovomab

Description:
Igovomab is a monoclonal antibody that has been investigated primarily for its potential use in cancer immunotherapy. It is designed to target specific antigens present on tumor cells, thereby enhancing the immune system's ability to recognize and destroy these cells. The CAS number 171656-50-1 identifies this compound uniquely in chemical databases. As a therapeutic agent, Igovomab may exhibit characteristics such as high specificity for its target, the ability to induce an immune response, and potential for use in combination with other treatments to improve efficacy. Its development has been part of ongoing research into monoclonal antibodies as a class of drugs that can provide targeted treatment options for various malignancies. The pharmacokinetics, safety profile, and clinical efficacy of Igovomab would be evaluated through clinical trials, which are essential for determining its therapeutic potential and regulatory approval. Overall, Igovomab represents a significant advancement in the field of targeted cancer therapies.
Formula:Unspecified
Synonyms:
  • Immunoglobulin G 1 (mouse monoclonal OC125F(AB′)2 F(ab′)2 fragment anti-human ovarian cancer antigen CA 125), disulfide with mouse monoclonal OC125F(AB′)2 light chain, dimer
  • Indimacis 125
  • Igovomab
  • Immunoglobulin G1, anti-(human CA 125 (carbohydrate antigen)) F(ab′)2 fragment (mouse monoclonal OC125F(AB′)2 γ1-chain), disulfide with mouse monoclonal OC125F(AB′)2 light chain, dimer
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 2 products.